Related Experiment Video
Updated: Oct 21, 2025

Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
ELTD1 Promotes Gastric Cancer Cell Proliferation, Invasion and Epithelial-Mesenchymal Transition Through MAPK/ERK
1Department of Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China.
Purpose:
Patients with gastric cancer (GC) often die from metastasis. However, the exact molecular mechanism underlying GC metastasis is complicated and still remains elusive. Epidermal growth factor, latrophilin and seven-transmembrane domain-containing 1 (ELTD1), has been reported to be involved in cancer metastasis, but its role in GC is still missing.
Patients And Methods:
We first analyzed the expression of ELTD1 in GC using public databases (TCGA, Oncomine, and GEO) and our clinical samples. The functions of ELTD1 in GC proliferation, invasion and metastasis were determined by in vitro and in vivo experiments. The functional mechanism of ETLD1 in GC was also investigated. Finally, the association between ELTD1 expression and the overall survival of GC patients was analyzed using public databases.
Results:
ELTD1 is significantly upregulated in GC tissues. Knockdown of ELTD1 inhibits GC cell proliferation, migration and invasion in vitro as well as tumor growth and metastasis in vivo, while ELTD1 overexpression obtains opposite results. Moreover, ELTD1 could promote epithelial to mesenchymal transition (EMT) in GC. Mechanistically, ELTD1 exerts its tumor-promoting effect by activating MAPK/ERK signaling. Subsequent studies demonstrated that ELTD1 could interact with C-terminal Src kinase (CSK) and inhibit its expression, which finally lead to MAPK/ERK activation. Data from TGCA and GEO both revealed that GC patients with high ELTD1 expression had poorer prognosis and the combination of ELTD1 with CSK showed better predictive performance.
Conclusion:
ELTD1 plays an oncogene role in GC through MAPK/ERK signaling via inhibiting CSK, which may be a useful prognostic predictor and potential therapeutic target for GC.
Insights
Epidermal growth factor, latrophilin and seven-transmembrane domain-containing 1 (ELTD1) promotes gastric cancer (GC) metastasis by activating MAPK/ERK signaling and inhibiting CSK. High ELTD1 expression predicts poor prognosis in GC patients.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Gastric cancer (GC) metastasis remains a primary cause of patient mortality.
- The molecular mechanisms driving GC metastasis are complex and not fully understood.
- Epidermal growth factor, latrophilin and seven-transmembrane domain-containing 1 (ELTD1) has been implicated in cancer metastasis, but its role in GC is unexplored.
Purpose of the Study:
- To investigate the expression and function of ELTD1 in gastric cancer.
- To elucidate the molecular mechanism by which ELTD1 influences GC progression.
- To evaluate ELTD1 as a prognostic biomarker for GC patients.
Main Methods:
- ELTD1 expression analysis in GC tissues and public databases (TCGA, Oncomine, GEO).
- In vitro and in vivo experiments to assess the effects of ELTD1 on GC cell proliferation, migration, invasion, and metastasis.
- Investigation of ELTD1's mechanism of action, including its interaction with C-terminal Src kinase (CSK) and its effect on MAPK/ERK signaling.
- Correlation analysis between ELTD1 expression and overall survival in GC patients.
Main Results:
- ELTD1 is significantly upregulated in GC tissues.
- ELTD1 knockdown inhibits GC cell proliferation, migration, invasion, tumor growth, and metastasis, while overexpression has opposite effects.
- ELTD1 promotes epithelial to mesenchymal transition (EMT) by activating MAPK/ERK signaling through inhibition of CSK.
- High ELTD1 expression is associated with poorer prognosis in GC patients, and the combination of ELTD1 and CSK improves predictive performance.
Conclusions:
- ELTD1 functions as an oncogene in GC by promoting metastasis via the MAPK/ERK signaling pathway through CSK inhibition.
- ELTD1 represents a potential prognostic predictor and therapeutic target for gastric cancer.
- Targeting ELTD1 may offer a novel strategy for managing GC metastasis.
Related Concept Videos
MAPK Signaling Cascades
Mitogens and the Cell Cycle
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

